Ms Sinéad McCool:

It was extremely robust and fully resourced and supported. It got to a stage where it was so successful that the opioid substitution programmes could be paused because they had delivered what they had set out to do. It was reinstated post Covid but that was due to issues relating to the pandemic. At the time, the leader there was a pharmacist. That helped them to understand the model and tailor it for use in community pharmacies.